Skip to main content
. 2011 Apr 13;9(66):1–19. doi: 10.1098/rsif.2011.0301

Table 3.

Approaches for using myocardial tissue engineering.

approach advantages disadvantages reference
cellular cardiomyoplasty (injection of cells only, direct/indirect) minimal invasive lack of knowledge of cell function, cell loss, effect to only endocardium [76,77]
in situ engineering (injection of cells and biomaterial) biomaterial act as supporting matrix while cells will regenerate infarction infancy stage [78,79]
injection of biomaterials alone matrix for homing autologous progenitor cells immunogenicity, as only natural polymers have been suggested [13]
left ventricular restraints (wrapping up the ventricle with biopolymer) does not involve cell injection prevents remodelling but does not repair damaged area [80]
tissue engineering ensures cells are delivered to desired area with minimal loss involves open heart surgery, more work is required to determine suitable cell type and material [81,82]